What question did this study set out to answer?

The research aims to assess the global burden of 21 nonmalignant digestive diseases from 1990 to 2023.

February 14, 2026International Journal of Surgery4 citationsOpen Access

Global, regional, and national burden of nonmalignant digestive diseases, 1990-2023: a systematic analysis from the GBD study 2023

FJFan JiangChinese People 's Liberation Army No.455 Hospital XLXueting LiXuzhou Central Hospital YCYoubo ChenAir Force General Hospital PLA

Puntos clave

The research aims to assess the global burden of 21 nonmalignant digestive diseases from 1990 to 2023.
Analyzed prevalence, incidence, deaths, and disability-adjusted life years (DALYs) using Global Burden of Disease data.
Calculated age-standardized rates (ASRs) for digestive diseases.
Examined temporal trends and evaluated associated risk factors.
Global age-standardized DALY rate for digestive diseases in 2023 was 1017.15 per 100,000.
Cirrhosis had an age-standardized DALY rate of 487.22 per 100,000 and mortality rate of 14.27.
GERD was the only disease to show upward trends in percent change.
Infants and older adults had the highest ASDR for overall digestive diseases.
Males aged 30-94 years showed a high burden of cirrhosis, indicating a need for targeted interventions.

Resumen

Background: This study assesses the global burden of 21 digestive diseases using data from the Global Burden of Disease (GBD) 2023 study. Methods: We analyzed prevalence, incidence, deaths, and disability-adjusted life years (DALYs) by calculating age-standardized rates (ASRs), examining temporal trends, and evaluating associated risk factors. Results: In 2023, the global age-standardized DALY rate (ASDR) for digestive diseases was 1017.15 (95% uncertainty interval UI 905.18, 1124.33 per 100,000, with an age-standardized mortality rate (ASMR) of 27.18 24.26, 30.06. Cirrhosis and other chronic liver diseases followed, with an ASDR of 487.22 430.22, 548.90 and an ASMR of 14.27 12.73, 15.97. Gastroesophageal reflux disease (GERD) was the only cause that presented upward trends in total percent change (TPC). The highest incidence of digestive diseases was observed in the United States Virgin Islands (9304.43 in 2023), while Egypt recorded the highest burden of cirrhosis (1389.31 in 2023). ASDR peaked among infants (<1 year) and older adults (≥95 years). Males aged 30–94 years carried a disproportionately high burden of cirrhosis, indicating an urgent need for age- and sex-specific interventions. For the ASDR of overall digestive diseases, metabolic risks—primarily high body mass index (BMI)—demonstrated notable regional variation. Middle and high-middle Socio-demographic Index (SDI) regions aligned with the global average (approximately 34 per 100,000), while low and low-middle SDI regions remained significantly lower (around 16 per 100,000). Conclusion: The declining trend in alcohol-related digestive diseases contrasts sharply with the rising burden of conditions driven by metabolic risks, such as NAFLD and GERD. Targeted interventions are urgently needed to address the high burden of common gastrointestinal disorders in high-risk regions and aging populations, as well as cirrhosis among middle-aged and younger men.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Jiang et al. (Thu,) studied this question.

synapsesocial.com/papers/699011712ccff479cfe58177 https://doi.org/https://doi.org/10.1097/js9.0000000000004481

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo